26 results
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
25 Mar 21
Agios Shareholders Approve Sale of Oncology Business to Servier
12:00am
pharmaceutical company.
Approximately 99.9% of the shares voted at the Special Meeting, representing approximately 90% of the outstanding shares
8-K
AGIO
Agios Pharmaceuticals Inc
25 Mar 21
Agios Shareholders Approve Sale of Oncology Business to Servier
12:00am
special meeting of stockholders (the “Special Meeting”). At the Special Meeting, Company stockholders voted on a proposal to approve the proposed sale … for the Special Meeting, there were 69,361,718 shares of Company common stock issued and outstanding. At the Special Meeting, 62,901,952 shares of Company
DEFA14A
AGIO
Agios Pharmaceuticals Inc
15 Mar 21
Additional proxy soliciting materials
5:14pm
Transaction or the timing of the special meeting of the stockholders of the Company, scheduled for March 25, 2021, at 9:00 a.m. Eastern Time, to be held
8-K
AGIO
Agios Pharmaceuticals Inc
15 Mar 21
Other Events
5:11pm
of the special meeting of the stockholders of the Company, scheduled for March 25, 2021, at 9:00 a.m. Eastern Time, to be held virtually via the internet
DEFM14A
AGIO
Agios Pharmaceuticals Inc
11 Feb 21
Proxy related to merger
4:19pm
, Massachusetts 02139
February 11, 2021
Dear Stockholder:
You are cordially invited to attend a special meeting of the stockholders of Agios … as described in the accompanying proxy statement.
At the special meeting, you will be asked to consider and vote upon the proposal to approve
PREM14A
8o5pw
29 Jan 21
Preliminary proxy related to merger
4:22pm
S-3ASR
ioxl9xpd6m9fps9n qxx
30 Apr 20
Automatic shelf registration
4:19pm
424B5
3e2imsp
8 Nov 19
Prospectus supplement for primary offering
5:03pm
424B5
6ai 8gqn4
6 Nov 19
Prospectus supplement for primary offering
4:07pm
8-K
EX-3.1
rc8flbz9 737qa95as
19 Dec 18
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
vpe seu2xy9ndyrle
19 Dec 18
Amendments to Articles of Incorporation or Bylaws
4:30pm
424B5
1d8171jriv92rc
11 Dec 14
Prospectus supplement for primary offering
12:00am
424B5
2huqg7c d0ite2
9 Dec 14
Prospectus supplement for primary offering
12:00am
424B4
vgjs p7meapzr
24 Apr 14
Prospectus supplement with pricing info
12:00am
8-K
EX-3.2
n23ligvmzm bnwdcfy
30 Jul 13
Unregistered Sales of Equity Securities
12:00am
8-K
EX-3.1
gtvr8q7hv948lfw4d
30 Jul 13
Unregistered Sales of Equity Securities
12:00am